Stockreport

Vor to Participate in Two Upcoming Investor Conferences

Vor Biopharma Inc.  (VOR) 
PDF CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that members of i [Read more]